Charles A Gersbach
Rooney Family Associate Professor of Biomedical Engineering
Appointments and Affiliations
- Rooney Family Associate Professor of Biomedical Engineering
- Associate Professor of Biomedical Engineering
- Associate Professor of Orthopaedic Surgery
- Affiliate of the Duke Initiative for Science & Society
- Member of the Duke Cancer Institute
- Office Location: 2353C CIEMAS, Durham, NC 27708
- Office Phone: (919) 613-2147
- Email Address: firstname.lastname@example.org
- Ph.D. Georgia Institute of Technology, 2006
- B.S. Georgia Institute of Technology, 2001
Dr. Gersbach's research interests are in gene therapy, biomolecular and cellular engineering, regenerative medicine, and synthetic biology.
Tissue Repair, Tissue Engineering
Polymer and Protein Engineering
- BME 260L: Modeling Cellular and Molecular Systems
- BME 394: Projects in Biomedical Engineering (GE)
- BME 493: Projects in Biomedical Engineering (GE)
- BME 494: Projects in Biomedical Engineering (GE)
- BME 562: Biology by Design (GE, MC)
- BME 712S: Biological Engineering Seminar Series (CBIMMS and CBTE)
- BME 791: Graduate Independent Study
- EGR 391: Projects in Engineering
- EGR 393: Research Projects in Engineering
- GENOME 293: Research Independent Study Genome Sciences
- ME 718S: Biological Engineering Seminar Series (CBIMMS and CBTE)
In the News
- Duke Awards Distinguished Professorships, Inducts New Bass Society Members (May 5, 2016)
- Gene editing treats disease in mice (Jan 4, 2016 | BBC News )
- Gene editing offers hope for treating Duchenne muscular dystrophy, studies find (Jan 4, 2016 | The New York Times )
- CRISPR Treats Genetic Disorder in Adult Mammal (Dec 31, 2015)
- Pratt Research Brings Precise Control to Gene Expression (Oct 27, 2015)
- Studying the Harm and Healing Power of Steroids (May 26, 2015)
- Engineers gain control of gene activity; new therapies may be ahead (Apr 6, 2015)
- Bacterial Defense Mechanism Targets Duchenne Muscular Dystrophy (Feb 19, 2015)
- Bacterial Defense Mechanism Targets Duchenne Muscular Dystrophy (Feb 18, 2015)
- Lighting Up the Duke 'D' With Genes (Feb 10, 2015)
- Hilton, IB; Gersbach, CA, Genetic engineering: Chemical control for CRISPR editing, Nature Chemical Biology, vol 13 no. 1 (2016), pp. 2-3 [10.1038/nchembio.2243] [abs].
- Brunger, JM; Zutshi, A; Willard, VP; Gersbach, CA; Guilak, F, CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues., Arthritis and Rheumatology (2016) [10.1002/art.39982] [abs].
- Housden, BE; Muhar, M; Gemberling, M; Gersbach, CA; Stainier, DYR; Seydoux, G; Mohr, SE; Zuber, J; Perrimon, N, Loss-of-function genetic tools for animal models: cross-species and cross-platform differences, Nature Reviews Genetics, vol 18 no. 1 (2016), pp. 24-40 [10.1038/nrg.2016.118] [abs].
- Black, JB; Adler, AF; Wang, HG; D'Ippolito, AM; Hutchinson, HA; Reddy, TE; Pitt, GS; Leong, KW; Gersbach, CA, Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells., Cell Stem Cell, vol 19 no. 3 (2016), pp. 406-414 [10.1016/j.stem.2016.07.001] [abs].
- Lee, J; Xu, L; Gibson, TM; Gersbach, CA; Sullenger, BA, Differential effects of toll-like receptor stimulation on mRNA-driven myogenic conversion of human and mouse fibroblasts., Biochemical and Biophysical Research Communications, vol 478 no. 3 (2016), pp. 1484-1490 [10.1016/j.bbrc.2016.08.159] [abs].